Abstract
Immunoglobulin G4-related disease (IgG4-RD) is a fibro-inflammatory condition characterized by infiltration of IgG4+ plasma cells into one or multiple organs. The disease mostly affects middle-aged to elderly males. Recently, there has been an increased awareness of the cutaneous manifestation of IgG4-RD as an isolated lesion either as a primary or as a secondary disease from involvement by a systemic disease. Clinically, cutaneous IgG4-RD presents as papules, plaques, and subcutaneous nodules involving most commonly the head and neck region. Tissue sections characteristically show an increased infiltration of IgG4+ polyclonal plasma cells and elevated ratio of IgG4+/IgG plasma cells of more than 40%, with a storiform pattern of fibrosis. Blood tests might show eosinophilia, along with high levels of IgG4 levels. Diagnosis requires an integration of clinical, pathological, and serological studies. IgG4-RD mimics several diseases and must be distinguished from inflammatory and neoplastic processes. In this book chapter, we describe this new yet challenging entity of cutaneous IgG4-RD describing the histologic and clinical manifestations and differential diagnosis and highlighting the importance of early recognition to ensure appropriate management. Dermatologists and dermatopathologists should be aware of this rare emerging entity to avoid misinterpretation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Kubo K, Yamamoto K. IgG4-related disease. Int J Rheum Dis. 2016;19(8):747–62.
Ibrahim SH, Zhang L, Freese DK. A 3-year-old with immunoglobulin G4-associated cholangitis. J Pediatr Gastroenterol Nutr. 2011;53(1):109–11.
Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21–30.
Himi T, Takano K, Yamamoto M, Naishiro Y, Takahashi H. A novel concept of Mikulicz’s disease as IgG4-related disease. Auris Nasus Larynx. 2012;39(1):9–17.
Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344(10):732–8.
Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68(8):1310–5.
Kamisawa T, Chari ST, Lerch MM, Kim MH, Gress TM, Shimosegawa T. Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut. 2013;62(9):1373–80.
Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010;34(2):202–10.
Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology. 2011;261(2):625–33.
Matsui S, Hebisawa A, Sakai F, et al. Immunoglobulin G4-related lung disease: clinicoradiological and pathological features. Respirology (Carlton, Vic). 2013;18(3):480–7.
Wick MR, O’Malley DP. Lymphadenopathy associated with IgG4-related disease: diagnosis & differential diagnosis. Semin Diagn Pathol. 2018;35(1):61–6.
Bennett AE, Fenske NA, Rodriguez-Waitkus P, Messina JL. IgG4-related skin disease may have distinct systemic manifestations: a systematic review. Int J Dermatol. 2016;55(11):1184–95.
Charrow A, Imadojemu S, Stephen S, Ogunleye T, Takeshita J, Lipoff JB. Cutaneous manifestations of IgG4-related disease (RD): a systematic review. J Am Acad Dermatol. 2016;75(1):197–202.
Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T. IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int. 2010;60(4):247–58.
Della Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy. 2014;69(2):269–72.
Yamada K, Hamaguchi Y, Saeki T, et al. Investigations of IgG4-related disease involving the skin. Mod Rheumatol. 2013;23(5):986–93.
Wang KC, Liao HT, Tsai CY. IgG4-related disease coexisting with autoimmune haemolytic anaemia. BMJ Case Reports. 2018;2018:bcr2018224814.
Sulieman I, Mahfouz A, AlKuwari E, et al. IgG4-related disease mimicking pancreatic cancer: case report and review of the literature. Int J Surg Case Rep. 2018;50:100–5.
Tokura Y, Yagi H, Yanaguchi H, et al. IgG4-related skin disease. Br J Dermatol. 2014;171(5):959–67.
Miyazawa H, Fujita Y, Iwata H, et al. Two cases of generalized pustular psoriasis complicated by IgG4-related disease. Br J Dermatol. 2018;179(2):537–9.
Nastri MMF, Novak GV, Sallum AEM, Campos LMA, Teixeira RAP, Silva CA. Immunoglobulin G4-related disease with recurrent uveitis and kidney tumor mimicking childhood polyarteritis nodosa: a rare case report. Acta Reumatologica Portuguesa. 2018;43(3):226–9.
Sato Y, Takeuchi M, Takata K, et al. Clinicopathologic analysis of IgG4-related skin disease. Mod Pathol. 2013;26(4):523–32.
Kondo M, Yamamoto S, Goto H, Nara Y. Nodules behind the ears: IgG4-related skin disease. Br J Dermatol. 2016;175(5):1056–8.
Deshpande V, Zen Y, Chan JKC, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181–92.
Takayama R, Ueno T, Saeki H. Immunoglobulin G4-related disease and its skin manifestations. J Dermatol. 2017;44(3):288–96.
Clerc A, Reynaud Q, Durupt S, et al. Elevated IgG4 serum levels in patients with cystic fibrosis. PLoS One. 2017;12(9):e0181888.
Funakoshi T, Lunardon L, Ellebrecht CT, Nagler AR, O’Leary CE, Payne AS. Enrichment of total serum IgG4 in patients with pemphigus. Br J Dermatol. 2012;167(6):1245–53.
Lehman JS, Smyrk TC, Pittelkow MR. Increased immunoglobulin (Ig) G4–positive plasma cell density and IgG4/IgG ratio are not specific for IgG4-related disease in the skin. Am J Clin Pathol. 2014;141(2):234–8.
Stone JH, Brito-Zeron P, Bosch X, Ramos-Casals M. Diagnostic approach to the complexity of IgG4-related disease. Mayo Clin Proc. 2015;90(7):927–39.
Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74(1):190–5.
Pitak-Arnnop P, Bellefqih S, Chaine A, Dhanuthai K, Bertrand JC, Bertolus C. Head and neck lesions of Kimura’s disease: exclusion of human herpesvirus-8 and Epstein-Barr virus by in situ hybridisation and polymerase chain reaction. An immunohistochemical study. J Craniomaxillofac Surg. 2010;38(4):266–70.
Kim GE, Kim WC, Yang WI, et al. Radiation treatment in patients with recurrent Kimura's disease. Int J Radiat Oncol Biol Phys. 1997;38(3):607–12.
Garcia Carretero R, Romero Brugera M, Rebollo-Aparicio N, Vazquez-Gomez O. Eosinophilia and multiple lymphadenopathy: Kimura disease, a rare, but benign condition. BMJ Case Reports. 2016;2016:bcr2015214211.
Adler BL, Krausz AE, Minuti A, Silverberg JI, Lev-Tov H. Epidemiology and treatment of angiolymphoid hyperplasia with eosinophilia (ALHE): a systematic review. J Am Acad Dermatol. 2016;74(3):506–12.e11.
Zarrin-Khameh N, Spoden JE, Tran RM. Angiolymphoid hyperplasia with eosinophilia associated with pregnancy: a case report and review of the literature. Arch Pathol Lab Med. 2005;129(9):1168–71.
D’Offizi G, Ferrara R, Donati P, Bellomo P, Paganelli R. Angiolymphoid hyperplasia with eosinophils in HIV infection. AIDS (London, England). Jul. 1995;9(7):813–4.
Altman DA, Griner JM, Lowe L. Angiolymphoid hyperplasia with eosinophilia and nephrotic syndrome. Cutis. 1995;56(6):334–6; quiz 342
Mukherjee B, Kadaskar J, Priyadarshini O, Krishnakumar S, Biswas J. Angiolymphoid hyperplasia with eosinophilia of the orbit and adnexa. Ocular Oncol Pathol. 2015;2(1):40–7.
Fontana SC, Borgstadt A, Fraga GR, Reeves AR, Andrews BT. Angiolymphoid hyperplasia with eosinophilia within a vascular malformation: case report and review of the literature. Ann Otol Rhinol Laryngol. 2016;125(9):775–8.
Marka A, Cowdrey MCE, Carter JB, Lansigan F, Yan S, LeBlanc RE. Angiolymphoid hyperplasia with eosinophilia and Kimura disease overlap, with evidence of diffuse visceral involvement. J Cutan Pathol. 2019;46(2):138–42.
Rimmer J, Andrews P, Lund VJ. Eosinophilic angiocentric fibrosis of the nose and sinuses. J Laryngol Otol. 2014;128(12):1071–7.
Deshpande V. IgG4 related disease of the head and neck. Head Neck Pathol. 2015;9(1):24–31.
Ziemer M, Koehler MJ, Weyers W. Erythema elevatum diutinum - a chronic leukocytoclastic vasculitis microscopically indistinguishable from granuloma faciale? J Cutan Pathol. 2011;38(11):876–83.
Ortonne N, Wechsler J, Bagot M, Grosshans E, Cribier B. Granuloma faciale: a clinicopathologic study of 66 patients. J Am Acad Dermatol. 2005;53(6):1002–9.
Cesinaro AM, Lonardi S, Facchetti F. Granuloma faciale: a cutaneous lesion sharing features with IgG4-associated sclerosing diseases. Am J Surg Pathol. 2013;37(1):66–73.
Kavand S, Lehman JS, Gibson LE. Granuloma Faciale and erythema Elevatum Diutinum in relation to immunoglobulin G4-related disease: an appraisal of 32 cases. Am J Clin Pathol. 2016;145(3):401–6.
Wu D, Lim MS, Jaffe ES. Pathology of castleman disease. Hematol Oncol Clin North Am. 2018;32(1):37–52.
Takeuchi M, Sato Y, Takata K, et al. Cutaneous multicentric castleman’s disease mimicking IgG4-related disease. Pathol Res Pract. 2012;208(12):746–9.
Uldrick TS, Polizzotto MN, Yarchoan R. Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Curr Opin Oncol. 2012;24(5):495–505.
Wang HW, Pittaluga S, Jaffe ES. Multicentric castleman disease: where are we now? Semin Diagn Pathol. 2016;33(5):294–306.
Uhara H, Saida T, Ikegawa S, et al. Primary cutaneous plasmacytosis: report of three cases and review of the literature. Dermatology. 1994;189(3):251–5.
Han XD, Lee SSJ, Tan SH, et al. Cutaneous plasmacytosis: a clinicopathologic study of a series of cases and their treatment outcomes. Am J Dermatopathol. 2018;40(1):36–42.
Miyagawa-Hayashino A, Matsumura Y, Kawakami F, et al. High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis--is this a cutaneous manifestation of IgG4-related disease? Hum Pathol. 2009;40(9):1269–77.
Takeoka S, Kamata M, Hau CS, et al. Evaluation of IgG4+ plasma cell infiltration in patients with systemic plasmacytosis and other plasma cell-infiltrating skin diseases. Acta Derm Venereol. 2018;98(5):506–11.
Mattoo H, Mahajan VS, Maehara T, et al. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016;138(3):825–38.
Koike T. IgG4-related disease: why high IgG4 and fibrosis? Arthritis Res Ther. 2013;15(1):103.
Mattoo H, Stone JH, Pillai S. Clonally expanded cytotoxic CD4(+) T cells and the pathogenesis of IgG4-related disease. Autoimmunity. 2017;50(1):19–24.
Kamekura R, Yamamoto M, Takano K, et al. Circulating PD-1(+)CXCR5(−)CD4(+) T cells underlying the immunological mechanisms of IgG4-related disease. Rheumatol Adv Pract. 2018;2(2):rky043.
Zhang X, Zhang P, Li J, et al. Different clinical patterns of IgG4-RD patients with and without eosinophilia. Sci Rep. 2019;9(1):16483.
Perugino CA, Stone JH. Treatment of IgG4-related disease: current and future approaches. Z Rheumatol. 2016;75(7):681–6. Behandlung IgG4-bedingter Erkrankungen: Aktuelle und zukunftige Vorgehensweisen.
Ingen-Housz-Oro S, Ortonne N, Elhai M, Allanore Y, Aucouturier P, Chosidow O. IgG4-related skin disease successfully treated by thalidomide: a report of 2 cases with emphasis on pathological aspects. JAMA Dermatol. 2013;149(6):742–7.
Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22(3):414–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Katerji, R., Smoller, B.R. (2021). Skin Manifestations of Immunoglobulin G4-Related Disease. In: Rongioletti, F., Smoller, B.R. (eds) New and Emerging Entities in Dermatology and Dermatopathology. Springer, Cham. https://doi.org/10.1007/978-3-030-80027-7_28
Download citation
DOI: https://doi.org/10.1007/978-3-030-80027-7_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-80026-0
Online ISBN: 978-3-030-80027-7
eBook Packages: MedicineMedicine (R0)